Bringing CAR T cell therapy trials to underserved populations.

Area of Science:

• Oncology
• Health Equity
• Cellular Therapy

Background:

• Cellular therapies offer promising cancer treatments but face access disparities.
• Public safety-net healthcare systems disproportionately serve minority and socioeconomically disadvantaged populations, exacerbating these disparities.
• Equitable access to advanced cancer treatments like cell therapy is a critical unmet need.

Purpose of the Study:

• To highlight the critical need for equitable access to cell therapies in cancer treatment.
• To discuss the pilot cell therapy program at the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine.
• To present this program as a potential national model for enhancing health equity in cancer care.

Main Methods:

• This study is a discussion of a pilot program.
• It reviews the strategic implementation of a cell therapy program within a large academic medical center.
• The focus is on addressing disparities in cancer care delivery.

Main Results:

• The pilot program at the Dan L Duncan Comprehensive Cancer Center is actively working to address disparities in cancer care.
• The program demonstrates a commitment to providing advanced cell therapies to underserved populations.
• The initiative has the potential to inform national strategies for health equity.

Conclusions:

• There is a critical need to improve equitable access to cell therapies for cancer patients, especially within safety-net healthcare systems.
• The Dan L Duncan Comprehensive Cancer Center's pilot program offers a model for addressing these disparities.
• Implementing such programs can significantly enhance health equity in cancer care nationwide.